Company Overview and News

2
Scaramucci's path to US$20b runs through a hot China market

3h theedgemarkets
BEIJING (July 17): An investment offering that most of the world has shunned is suddenly all the rage in China, and money managers from UBS Group AG to SkyBridge Capital are moving to grab a slice of the bounty.
UBS UBS.PRDCL ULSGF

27
Did Bullish Analysts Misfire on Netflix Stock?

3h investorplace
Ahead of Q2 earnings, it was starting to feel a little bit like a game of one-upmanship when it comes to Netflix, Inc. (NASDAQ:NFLX) stock. As Netflix stock continues to soar – it had more than doubled this year before Monday’s release – several major Wall Street firms rushed to apply ever-higher targets.
FB GS.PRB GS.PRA NFLX CS ATVI GS ZNGA GLSSP UBS UBS.PRDCL DIS JBK GSC GS.PRICL TFG GSJ GS.PRJ GS.PRI GS.PRD GS.PRC GJS GS.PRN ULSGF GS.PRK

2
Art Basel owner chases Asia’s rich with new Singapore fair

3h bworldonline
MCH Group AG, the owner of Art Basel, is launching a new art fair in Singapore starting next year to take advantage of the growing wealth in Asia, which is minting millionaires faster than any other region in the world.
UBS UBS.PRDCL ULSGF

2
Deutsche (DB) Reports Preliminary Q2 Profit, Stock Gains 8%

4h zacks
Deutsche Bank AG (DB - Free Report) has gained more than 8% on the NYSE following the release of its preliminary second-quarter 2018 results. The company expects to report income before income taxes of about €700 million ($834.8 million) and net income of nearly €400 million ($477 million) for the quarter.
HCS.PRB DB HCS HSB 0005 UBS HSEA UBS.PRDCL HSEB HSBC.PRA HSBC ULSGF HBCYF

9
Lifehacks for when a robot wants your job

2018-07-16 bworldonline
CAN’T CODE, or speak Bahasa? Didn’t go to school with a CEO’s son or daughter? A robot will take your trading seat. Read on if you want to save your job.
NMR BCS.PRD BCS BCS.PRC DB BCS.PRA GS.PRB GS.PRA SFTBF 83SF GS GLSSP D05 83SK 8604 UBS DBSDF NRSCF UBS.PRDCL RWA SFTBY 47MC JBK DBSDY GSC GS.PRICL TFG GSJ GS.PRJ GS.PRI BCS.PR N33 GS.PRD GS.PRC 9984 GJS GS.PRN ULSGF GS.PRK

2
Deutsche Bank Surprises With Profit Beat Welcomed by Investors - Bloomberg

2018-07-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DB UBS UBS.PRDCL ULSGF

7
Infosys Limited, Inc. (INFY) CEO Salil Parekh on Q1 2019 Results - Earnings Call Transcript

2018-07-16 seekingalpha
Ladies and gentlemen, good day, and welcome to the Infosys Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode. And there will be an opportunity for you to ask questions, after the presentation concludes. [Operator Instructions] Please note that this conference is being recorded.
WFC WFCNP WFC.WS DB WFC.PRL INFY DTK WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO UBS WFC.PRN INFY UBS.PRDCL WFC.PRY WFC.PRX WFC.PRW WFC.PRV ULSGF

2
China Economy Remains Robust as Country Readies for Trade War - Bloomberg

2018-07-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
UBS UBS.PRDCL ULSGF

2
Art Basel Owner Chases Asia's Rich With New Singapore Fair - Bloomberg

2018-07-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
UBS UBS.PRDCL ULSGF

5
The most expensive city in the world to eat in

2018-07-13 theage.com.au
The Swiss city is the most expensive in the world for food, according to UBS Group AG's Prices and Earnings report for 2018, a survey ranking global city prices, earning levels, purchasing power and working time to buy common goods.
DSLV VIIX DGLD CSSLF VIIZ CS CSGKF UGLD UBS UBS.PRDCL ZIV USLV TVIX ULSGF XIV

5
The most expensive city in the world to eat in

2018-07-13 smh.com.au
The Swiss city is the most expensive in the world for food, according to UBS Group AG's Prices and Earnings report for 2018, a survey ranking global city prices, earning levels, purchasing power and working time to buy common goods.
DSLV VIIX DGLD CSSLF VIIZ CS CSGKF UGLD UBS UBS.PRDCL ZIV USLV TVIX ULSGF XIV

2
Oil Gauges Plunge as Bulls Rattled by Trade War, Libyan Barrels - Bloomberg

2018-07-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
UBS UBS.PRDCL ULSGF

2
MOVES-UBS names Susan Elolampi as head of family office coverage - memo

2018-07-12 reuters
(Reuters) - UBS Group AG (UBSG.S) named J.P. Morgan veteran Susan Elolampi as head of family office coverage, corporate client solutions in the Americas, according to an internal memo.
UBS UBS.PRDCL ULSGF

5
These Are the Most Expensive Cities in the World - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DSLV VIIX DGLD CSSLF VIIZ CS CSGKF UGLD UBS UBS.PRDCL ZIV USLV TVIX ULSGF XIV

3
Immediate Income: Why Individual Stocks Matter

2018-07-12 seekingalpha
Multiple types of securities can be used to find high yields but none are safe as individual stocks.
MLPA UNIT CTL CIF OXLCO OXLCN OXLC PSF KNOP UBS AMZA UBS.PRDCL ULSGF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

14h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

15h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to UBS / UBS Group AG on message board site Silicon Investor.

UBS - Unique Broadband Systems Cheap Capital IQ Subsitute
NeoStem (NBS) Subsidiary, PCT, gains NEW CLIENT BRLI-- A substantially undervalued micro-cap
Whou0027s getting drunk in preperation of hitting the clubs? QSI a wholly-owned subsidiary of Quintek Technologies
ABXA.ob ABX air former subsid Airborne CXN (Fat substitute in food
TIW EXCEEDS FIVE MILLION SUBSCRIBERS IN CENTRAL AND EASTERN Analysts and Calls -- UBS
CUSIP: H42097107